Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence

Journal of Clinical and Experimental Neuropsychology

Volumn 32, Issue 7, 2010, Pages 704-718

  Iudicello, Jennifer E ^a,b   Woods, Steven P ^a   Vigil, Ofilio ^a   Cobb Scott, J ^a,b   Cherner, Mariana ^a   Heaton, Robert K ^a   Hampton Atkinson, J ^a,c   Grant, Igor ^a   Atkinson, J H ^d   Ellis, R J ^d,d   McCutchan, J A ^d   Marcotte, T D ^d   Bentley, H ^d   Sherman, M ^d   Hale, B R ^d   Letendre, S ^d,d   Capparelli, E ^d   Schrier, R ^d   Marquie Beck, J ^d   Alexander, T ^d   Moore, D J ^d   Dawson, M ^d   Jernigan, T ^d   Fennema Notestine, C ^d   Archibald, S L ^d   Hesselink, J ^d   Annese, J ^d   Taylor, M J ^d   Schweinsburg, B C ^d   Masliah, E ^d   Everall, I ^d,d   Achim, C ^d   Richman, D ^d   Smith, D M ^d   Lipton, S ^d   von Jaeger, R ^d   Gamst, A C ^d   Cushman, C ^d   Masys, D R ^d   Abramson, I ^d   Ake, C ^d   Vaida, F ^d   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d NONE

Author keywords

Affective disorders; Central nervous system; Cognition; Dependence; Drug abstinence; Methamphetamine

Indexed keywords

METHAMPHETAMINE;

ADDICTION; ADULT; CANNABIS SMOKING; CHEMICALLY INDUCED; COGNITIVE DEFECT; COMPLICATION; CONVALESCENCE; DRINKING BEHAVIOR; DRUG ABUSE; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEARNING; LONGITUDINAL STUDY; MALE; MEMORY; MENTAL DISEASE; MENTAL FUNCTION; MOOD DISORDER; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SHORT TERM MEMORY; SOCIOECONOMICS;

ADULT; ALCOHOL DRINKING; AMPHETAMINE-RELATED DISORDERS; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LEARNING; LONGITUDINAL STUDIES; MALE; MARIJUANA SMOKING; MEMORY; MEMORY, SHORT-TERM; MENTAL DISORDERS; MENTAL PROCESSES; METHAMPHETAMINE; MOOD DISORDERS; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RECOVERY OF FUNCTION; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 77955062548     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390903512637     Document Type: Article

References (64)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
2. Army Individual Test Battery. (1944). Manual of directions and scoring. Washington, DC: War Department, Adjutant General's Office.
3. Baberg, H. T., Nelesen, R. A., & Dimsdale, J. E. (1996). Amphetamine use: Return of an old scourge in a consultation psychiatry setting. American Journal of Psychiatry, 153, 789-793.
4. Ball, S. A., Carroll, K. M., & Rounsaville, B. J. (1994). Sensation seeking, substance abuse, and psychopathology in treatment-seeking and community cocaine abusers. Journal of Consulting and Clinical Psychology, 62, 1053-1057.
5. Beck, A. T., & Steer, R. A. (1987). BDI: Beck Depression Inventory: Manual. San Antonio, TX: Psychological Corporation.
6. Benedict, R. H. (1997). Brief Visuospatial Memory Test- Revised. Odessa, FL: Psychological Assessment Resources.
7. Benedict, R. H., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins Verbal Learning Test-Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 43-55.
8. Benton, A. L., Hamsher, K., & Sivan, A. B. (1994). Multilingual Aphasia Examination. Iowa City, IA: AJA Associates.
9. Brandt, J., & Benedict, R. H. B. (2001). Hopkins Verbal Learning Test, Revised. Professional manual. Lutz, FL: Psychological Assessment Resources.
10. Carey, C. L., Woods, S. P., Gonzalez, R., Conover, E., Marcotte, T., Grant, I., et al. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26, 307-319.
11. Chang, L., Alicata, D., Ernst, T., & Volkow, N. D. (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction, 102, 16-32.
12. Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., et al. (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Research, 114, 65-79.
13. Cherner, M., Suarez, P., Casey, C., Deiss, R., Letendre, S., Marcotte, T., et al (in press). Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug and Alcohol Dependence.
14. Chou, Y. H., Huang, W. S., Su, T. P., Lu, R. B., Wan, F. J., & Fu, Y. K. (2007). Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study. European Neuropsychopharmacology, 17, 46-52.
15. Cicerone, K. D., Dahlberg, C., Malec, J. F., Langenbahn, D. M., Felicetti, T., Kneipp, S., et al. (2005). Evidence-based cognitive rehabilitation: Updated review of the literature from 1998 through 2002. Archives of Physical Medicine and Rehabilitation, 86, 943-950.
16. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
17. Cretzmeyer, M., Sarrazin, M. V., Huber, D. L., Block, R. I., & Hall, J. A. (2003). Treatment of methamphetamine abuse: Research findings and clinical directions. Journal of Substance Abuse Treatment, 24, 267-277.
18. Diehr, M. C., Heaton, R. K., Miller, W., & Grant, I. (1998). The Paced Auditory Serial Addition Task (PASAT): Norms for age, education, and ethnicity. Assessment, 5, 375-387.
19. Ernst, T., Chang, L., Leonedo-Yee, M., & Speck, O. (2000). Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology, 54, 1344-1349.
20. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric Press.
21. Gladsjo, J. A., Schuman, C. C., Evans, J. D., Peavy, G. M., Miller, S. W., & Heaton, R. K. (1999). Norms for letter and category fluency: Demographic corrections for age, education, and ethnicity. Assessment, 6, 147-178.
22. Golden, C. J. (1978). Stroop Color and Word Test. Chicago: Stoelting.
23. Golden, C. J., & Freshwater, S. M. (2002). Stroop Color and Word Test. Chicago: Stoelting.
24. Grant, I. (1987). Alcohol and the brain: Neuropsychological correlates. Journal of Consulting and Clinical Psychology, 55, 310-324.
25. Grant, I., Reed, R., & Adams, K. M. (1987). Diagnosis of intermediate-duration and subacute organic mental disorders in abstinent alcoholics. Journal of Clinical Psychiatry, 48, 319-323.
26. Heaton, R. K., Grant, I., & Matthews, C. G. (1991). Comprehensive norms for an expanded Halstead Reitan Battery: Demographic corrections, research findings, and clinical applications. Odessa, FL: Psychological Assessment Resources.
27. Heaton, R. K., Kirson, D., Velin, R. A., Grant, I., & the HNRC Group. (1994). The utility of clinical ratings for detecting cognitive change in HIV infection. In I. Grant & A Martin (Eds.), Neuropsychology of HIV infection (pp. 188- 206). New York: Oxford University Press.
28. Heaton, R. K., Taylor, M. J., & Manly, J. J. (2002). Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In D. S. Tulsky, R. K. Heaton, G. Chelune, R. Ivnik, R. A. Bornstein, A. Prifitera, & M. Ledbetter (Eds.), Clinical interpretation of the WAIS- III and WMS-III. San Diego, CA: Academic Press.
29. Hillhouse, M. P., Marinelly-Casey, P., Gonzales, R., Ang, A., & Rawson, R. A. (2007). Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction, 102, 84-95.
30. Hoffman, W. F., Moore, M., Templin, R., McFarland, B., Hitzemann, R. J., & Mitchell, S. H. (2006). Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology, 188, 162-170.
31. Johanson, C. E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., et al. (2006). Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology, 185, 327-338.
32. Kalechstein, A. D., Newton, T. F., & Green, M. (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 215-220.
33. Kalechstein, A. D., Newton, T. F., Longshore, D., Anglin, M. D., van Gorp, W. G., & Gawin, F. H. (2000). Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 480-484.
34. Kløve, H. (1963). Clinical neuropsychology. In F. M. Forster (Ed.), The medical clinics of North America. New York: Saunders.
35. Kongs, S. K., Thompson, L. L., Iverson, G. L., & Heaton, R. K. (2000). Wisconsin Card Sorting Test-64 card computerized version. Odessa, FL: Psychological Assessment Resources.
36. London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., et al. (2004). Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry, 61, 73-84.
37. McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbet, R., Brasic, J., et al. (2008). Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse, 62, 91-100.
38. McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998). Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428. Journal of Neuroscience, 18, 8417-8422.
39. McNair, D. M., Lorr, M., & Droppleman, L. F. (1981). Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
40. Newton, T. F., Kalechstein, A. D., Duran, S., Vansluis, N., & Ling, W. (2004). Methamphetamine abstinence syndrome: Preliminary findings. American Journal on Addictions, 13, 248-255.
41. Nordahl, T. E., Salo, R., Natsuaki, Y., Galloway, G. P., Waters, C., Moore, C. D., et al. (2005). Methamphetamine users in sustained abstinence: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry, 62, 444-452.
42. Nordahl, T. E., Salo, R., Possin, K., Gibson, D. R., Flynn, N., Leamon, M., et al. (2002). Low N-acetyl aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine dependent subjects: A preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Research, 116, 43-52.
43. Olsen, E. R. (1977). Intracranial hemorrhage and amphetamine usage. Review of the effects of amphetamines on the central nervous system. Angiology, 28, 464-471.
44. Peck, J. A., Reback, C. J., Yang, X., Rotheram, E., & Shoptaw, S. (2005). Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 82, 100-108.
45. Psychological Corporation. (1997). Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). San Antonio, TX: Author.
46. Rawson, R. A., Huber, A., Brethen, P., Obert, J., Gulati, V., Shoptaw, S., et al. (2002). Status of methamphetamine users 2-5 years after outpatient treatment. Journal of Addictive Diseases, 21, 107-119.
47. Reitan, R. M., & Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation. Tucson, AZ: Neuropsychology Press.
48. Reitan, R. M., & Wolfson, D. (1993) The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation, (2nd ed.). Tucson, AZ: Neuropsychology Press.
49. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10, 1-14.
50. Robbins, L. N., Helzer, J. E., Croughan, J., & Ratcliff, K. S. (1981). National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity. Archives of General Psychiatry, 38, 381-389.
51. Rourke, S. B., & Grant, I. (1995). Neuropsychological deficits in male alcoholics: Part II. Using clinical ratings to delineate the effects of interim drinking and length of abstinence on the prevalence of deficits. Journal of the International Neuropsychological Society, 1, 328.
52. Rourke, S. B., & Grant, I. (2009). The neurobehavioral consequences of alcoholism. In I. Grant & K. M. Adams (Eds.), Neuropsychological assessment of neuropsychiatric and neuromedical disorders (3rd ed., pp. 398-454). New York: Oxford University Press.
53. Sadek, J. R., Vigil, O., Grant, I., & Heaton, R. K. (2007). The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. Journal of Clinical and Experimental Neuropsychology, 29, 266-276.
54. Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., et al. (2007). Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychological Review, 17, 275-297.
55. Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., et al. (2001). Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. American Journal of Psychiatry, 158, 1206-1214.
56. Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., et al. (2006). Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry, 63, 90-100.
57. Simon, S. L., Dacey, J., Glynn, S., Rawson, R., & Ling, W. (2004). The effect of relapse on cognition in abstinent methamphetamine abusers. Journal of Substance Abuse Treatment, 27, 59-66.
58. Substance Abuse and Mental Health Services Administration (SAMHSA). (2007). Results from the 2006 National Survey on Drug Use and Health: National findings. Rockville, MD: Author.
59. US Department of Health and Human Services (1999). Mental Health: A Report of the Surgeon General - Executive Summary. Rockville, MD: U.S. Department of Health and Human Services.
60. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Franceschi, D., Sedler, M., et al., (2001a). Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience, 21, 9414-9418.
61. Volkow, N. D., Chang, L., Wang, G. J., Fowler, J. S., Leonido-Yee, M. Franceschi, D., et al. (2001b). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158, 377-382.
62. Wang, G. J., Volkow, N. D., Chang, L., Miller, E., Sedler, M., Hitzemann, R., et al. (2004). Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. American Journal of Psychiatry, 161, 242-248.
63. Wilkinson, G. S. (1993). Wide Range Achievement Test administration manual (3rd ed.). Wilmington, DE: Wide Range.
64. Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., et al. (2004). Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13, 181-190.